.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Colorcon
Boehringer Ingelheim
Moodys
Queensland Health
Mallinckrodt
Federal Trade Commission
Citi
US Army

Generated: July 23, 2017

DrugPatentWatch Database Preview

OXSORALEN Drug Profile

« Back to Dashboard

What is the patent landscape for Oxsoralen, and what generic Oxsoralen alternatives are available?

Oxsoralen is a drug marketed by Valeant Pharm Intl and Dow Pharm and is included in two NDAs.

The generic ingredient in OXSORALEN is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.

Summary for Tradename: OXSORALEN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list82
Clinical Trials: see list1
Patent Applications: see list3,180
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXSORALEN at DailyMed

Pharmacology for Tradename: OXSORALEN

Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl
OXSORALEN
methoxsalen
LOTION;TOPICAL009048-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Dow Pharm
OXSORALEN-ULTRA
methoxsalen
CAPSULE;ORAL019600-001Oct 30, 1986ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Argus Health
Fish and Richardson
Johnson and Johnson
Harvard Business School
Dow
Express Scripts
Queensland Health
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot